Zeynep Karakoy

Zeynep Karakoy

Auto-generated profile, based on publicly available information

Zeynep Karakoy

Department of Pharmacology, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
ZKZeynep Karaköy
Zeynep Karaköy
ECELIF CADIRCI
ELIF CADIRCI
BDBusra Dincer
Busra Dincer
Nflammation is a response to various injuries, illnesses, and severe trauma. The primary function of inflammation is to combat pathogens, eliminate them from the body, and initiate wound healing. However, inflammation also contributes to numerous diseases, such as cancer, cardiovascular disease, diabetes, obesity, osteoporosis, rheumatoid arthritis, inflammatory bowel disease, and asthma. As the importance of nutrition in maintaining human health has become increasingly recognized, the consumption of natural antioxidants has gained popularity, especially in developed countries. A growing body of research has shown that consuming foods rich in lycopene can protect individuals from a range of conditions, including cancer, heart disease, and other diseases. As a result, lycopene is gaining recognition as a potential protective antioxidant in the fields of medicine and pharmacology. This review aims to highlight the effects of lycopene on inflammatory diseases and provide a foundational understanding for researchers interested in further research on lycopene. Cite this article as: Karaköy Z, Cadirci E, Dincer B. A new target in inflammatory diseases: Lycopene. Eurasian J Med., 2022;54(Suppl. 1):S23-S28.

3 July 2023 in ChemistrySelect
Verified
Journal Article
Closed access
IMİrEm Bozbey Merde
İrEm Bozbey Merde
GÖGülce Taşkor Önel
Gülce Taşkor Önel
SASenem Akkoç
Senem Akkoç
ZKZeynep Karaköy
Zeynep Karaköy
BTBurçin Türkmenoğlu
Burçin Türkmenoğlu

20 September 2024 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
MÇMuhammet Çelik
Muhammet Çelik
PAPelin Aydin
Pelin Aydin
MCMaide Sena Civelek
Maide Sena Civelek
NANurullah Akgun
Nurullah Akgun
ZKZeynep Karakoy
Zeynep Karakoy
ETErdem TOKTAY
Erdem TOKTAY

9 February 2025 in The Protein Journal
Verified
Journal Article
Closed access
PDF file
HHHamza Halici
Hamza Halici
HUHarun Un
Harun Un
SCSaffet Celik
Saffet Celik
ZKZeynep Karakoy
Zeynep Karakoy
ZBZafer Bayraktutan
Zafer Bayraktutan
FMFiliz Mercantepe
Filiz Mercantepe

7 March 2024 in Reproductive Sciences
Verified
Journal Article
Open access
PDF file
ABAyse Bozkurt
Ayse Bozkurt
ZKZeynep Karakoy
Zeynep Karakoy
PAPelin Aydin
Pelin Aydin
BOBengul Ozdemir
Bengul Ozdemir
ETErdem TOKTAY
Erdem TOKTAY
ECELIF CADIRCI
ELIF CADIRCI
This study aimed to examine the effect of Phosphodiesterase 4 (PDE4) inhibition on Aquaporin-5 (AQP5) and its potential cell signaling pathway in the ovarian ischemia reperfusion (OIR) model. Thirty adult female rats were divided into five groups: Group 1; Control: Sham operation, Group 2; OIR that 3 hour ischemia followed by 3 hour reperfusion, Group 3; OIR + Rolipram 1 mg/kg, Group 4; OIR + Rolipram 3 mg/kg, Group 5; OIR + Rolipram 5 mg/kg. Rolipram was administered intraperitoneally to the rats in groups 3-4 and 5 at determined doses 30 minutes before reperfusion. From ovary tissue; Tumor necrosis factor-a (TNF-α), Cyclic adenosine monophosphate (cAMP), Nuclear factor kappa (NF-κB), Interleukin-6 (IL-6), Phosphodiesterase 4D (PDE4D), Mitogen-activated protein kinase (MAPK) and AQP5 levels were measured by ELISA. We also measured the level of AQP5 in ovary tissue by real-time reverse-transcription polymerase chain reaction (RT-PCR). In the OIR groups; TNF-α, NF-κB, IL-6, MAPK inflammatory levels increased, and cAMP and AQP5 levels decreased, which improved with the administration of rolipram doses. Also histopathological results showed damaged ovarian tissue after OIR, while rolipram administration decrased tissue damage in a dose dependent manner. We propose that the protective effect of PDE4 inhibition in OIR may be regulated by AQP5 and its potential cell signaling pathway and may be a new target in OIR therapy. However, clinical studies are needed to appraise these data in humans.

7 February 2025 in The Protein Journal
Verified
Journal Article
Closed access
PDF file
MÇMine Gürsaç Çelik
Mine Gürsaç Çelik
MKMehmet Koca
Mehmet Koca
ZHzekai halici
zekai halici
TTTaha Tavaci
Taha Tavaci
HHHamza Halici
Hamza Halici
ZBZafer Bayraktutan
Zafer Bayraktutan